The Queensland Court of Appeal has knocked back a challenge by jailed investment guru Dr Roger Munro to his conviction on three counts of fraud, which landed him a four-and-a-half month prison sentence.
Super Retail Group’s former chief legal officer and company secretary has brought court proceedings to enforce what she claims was a settlement reached three days after her employment was terminated in May.
A contradictor has argued against Monash IVF’s bid for orders allowing it to retain embryos as evidence in a class action, saying the Victorian Supreme Court has no power to make orders inconsistent with the company’s statutory obligation to store embryos for a maximum of five years.
The previous head of First Nations strategy of the Collingwood Football Club has brought Fair Work proceedings against their former employer, claiming they were unfairly terminated after making several complaints against CEO Craig Kelly about alleged racially insensitive comments.
In submissions to the High Court, the applicant in a class action brought on behalf of Arrium shareholders against KMPG has attacked the Attorney-General’s argument that a contingency fee order is a neutral factor in assessing the accounting firm’s bid to move the case from Victoria.
A former EY partner and ousted board member at National Tiles has lost his $1 million claim alleging the company breached implied terms in a contract by requiring him to sign a “draconian, unreasonable and unacceptable” share agreement.
Two units of the Commonwealth Bank of Australia on Monday pleaded guilty and were hit with $48,000 in penalties for denying staff $1.67 million in long service leave entitlements.
Experts say the chaos of last month’s CrowdStrike outage is likely to spark a flurry of litigation both overseas and at home, including class actions, but lawyers bringing the claims will face significant hurdles.
Booktopia’s administrators have been given more time to try to sell the online bookseller after receiving 100 expressions of interest, with a judge finding it could yield greater returns for its 170,000 creditors, who are owed a total of $68 million.
A law firm is investigating claims against the manufacturers of popular heartburn and acid reflux drugs, alleging they could be responsible for causing stomach cancers and kidney failure in approximately 100,000 people.